Matches in Wikidata for { <http://www.wikidata.org/entity/Q37649877> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q37649877 description "article científic" @default.
- Q37649877 description "article scientifique" @default.
- Q37649877 description "articolo scientifico" @default.
- Q37649877 description "artigo científico" @default.
- Q37649877 description "artículu científicu espublizáu en 2017" @default.
- Q37649877 description "bilimsel makale" @default.
- Q37649877 description "scientific article published on 13 February 2017" @default.
- Q37649877 description "vedecký článok" @default.
- Q37649877 description "vetenskaplig artikel" @default.
- Q37649877 description "videnskabelig artikel" @default.
- Q37649877 description "vědecký článek" @default.
- Q37649877 description "wetenschappelijk artikel" @default.
- Q37649877 description "wissenschaftlicher Artikel" @default.
- Q37649877 description "наукова стаття, опублікована в лютому 2017" @default.
- Q37649877 description "научни чланак" @default.
- Q37649877 description "مقالة علمية نشرت في 13 فبراير 2017" @default.
- Q37649877 name "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 name "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 name "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 type Item @default.
- Q37649877 label "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 label "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 label "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 prefLabel "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 prefLabel "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 prefLabel "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment." @default.
- Q37649877 P1433 Q37649877-C47CB289-A5FA-44C2-8B1B-1B5249CDFE56 @default.
- Q37649877 P1476 Q37649877-2020B84B-E92E-4C0F-8D68-F4A881874488 @default.
- Q37649877 P2093 Q37649877-10A51085-E6FA-40CB-94CA-927ED394961E @default.
- Q37649877 P2093 Q37649877-68D901D3-2245-43B9-8871-924B59BC1D39 @default.
- Q37649877 P2093 Q37649877-D65BDF6D-0DF3-4A98-9788-C9AD492AA69C @default.
- Q37649877 P275 Q37649877-727f1eae-40e6-4f51-b969-da4f1bc8654c @default.
- Q37649877 P2860 Q37649877-04463ADC-0691-44DB-9B53-70A6124C31D2 @default.
- Q37649877 P2860 Q37649877-17F39419-C172-4C60-B05E-8AA5C5FC5016 @default.
- Q37649877 P2860 Q37649877-211D4DCA-3A0B-4DB8-B182-0F063FDC4CE5 @default.
- Q37649877 P2860 Q37649877-2CF5A76F-9900-4A97-A4C5-D029F0F261B5 @default.
- Q37649877 P2860 Q37649877-4B2FC7C8-E17C-40FE-91D9-8100154A438D @default.
- Q37649877 P2860 Q37649877-7D28429C-775D-4B2F-B43F-84A6EF23BCAD @default.
- Q37649877 P2860 Q37649877-AA9E9613-E930-43CB-B52E-8B94BE5AF102 @default.
- Q37649877 P2860 Q37649877-B305E6AD-9686-45D7-A65F-596E067844EB @default.
- Q37649877 P2860 Q37649877-B8168F3E-AC31-480A-88C7-76589C7B6181 @default.
- Q37649877 P304 Q37649877-455FD441-D7BE-4606-B8D5-E6BE835CDD6C @default.
- Q37649877 P31 Q37649877-CA76B00D-535E-4F4A-AB4A-7DB9F354C4AF @default.
- Q37649877 P356 Q37649877-32EC18F3-E911-4FA8-B5F7-1018E6768864 @default.
- Q37649877 P407 Q37649877-98CB9E65-2DBD-4D3F-A824-94BEA9014113 @default.
- Q37649877 P478 Q37649877-2580CD26-566D-4262-BE42-C994C254929F @default.
- Q37649877 P50 Q37649877-FFB74B31-6F32-4D8F-AB4E-A59589FD6D53 @default.
- Q37649877 P577 Q37649877-927A66D1-B783-4F8B-921E-86C19B418989 @default.
- Q37649877 P6216 Q37649877-51558548-9a17-4a5e-a579-4186fdc223e8 @default.
- Q37649877 P698 Q37649877-D76706B2-F2AA-405B-AF97-27CFCF1EDC6C @default.
- Q37649877 P921 Q37649877-CE3076B1-1747-466C-8007-B70A70C9125B @default.
- Q37649877 P932 Q37649877-EB68BB8B-A7D1-47D7-A0A4-B6FF417AD7DA @default.
- Q37649877 P356 DDDT.S125459 @default.
- Q37649877 P698 28243060 @default.
- Q37649877 P1433 Q2566724 @default.
- Q37649877 P1476 "Pharmacokinetics of conivaptan use in patients with severe hepatic impairment" @default.
- Q37649877 P2093 "Byron Kaelin" @default.
- Q37649877 P2093 "Jerry Fox" @default.
- Q37649877 P2093 "Leo Pavliv" @default.
- Q37649877 P275 Q18810331 @default.
- Q37649877 P2860 Q22241512 @default.
- Q37649877 P2860 Q35189238 @default.
- Q37649877 P2860 Q36138277 @default.
- Q37649877 P2860 Q37277688 @default.
- Q37649877 P2860 Q46885228 @default.
- Q37649877 P2860 Q50947709 @default.
- Q37649877 P2860 Q53805992 @default.
- Q37649877 P2860 Q57319258 @default.
- Q37649877 P2860 Q86257358 @default.
- Q37649877 P304 "373-382" @default.
- Q37649877 P31 Q13442814 @default.
- Q37649877 P356 "10.2147/DDDT.S125459" @default.
- Q37649877 P407 Q1860 @default.
- Q37649877 P478 "11" @default.
- Q37649877 P50 Q89375197 @default.
- Q37649877 P577 "2017-02-13T00:00:00Z" @default.
- Q37649877 P6216 Q50423863 @default.
- Q37649877 P698 "28243060" @default.
- Q37649877 P921 Q323936 @default.
- Q37649877 P932 "5315214" @default.